Compare PPIH & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPIH | CDXS |
|---|---|---|
| Founded | 1909 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.3M | 256.3M |
| IPO Year | 1994 | 2008 |
| Metric | PPIH | CDXS |
|---|---|---|
| Price | $25.20 | $1.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 115.5K | ★ 796.1K |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.61 | 43.82 |
| EPS | ★ 0.22 | N/A |
| Revenue | N/A | ★ $138,590,000.00 |
| Revenue This Year | $8.81 | $7.73 |
| Revenue Next Year | $9.33 | $14.24 |
| P/E Ratio | $116.55 | ★ N/A |
| Revenue Growth | N/A | ★ 32.30 |
| 52 Week Low | $21.00 | $0.96 |
| 52 Week High | $36.72 | $3.87 |
| Indicator | PPIH | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 23.79 |
| Support Level | $24.30 | $1.10 |
| Resistance Level | $29.48 | $1.86 |
| Average True Range (ATR) | 0.84 | 0.15 |
| MACD | 0.19 | -0.07 |
| Stochastic Oscillator | 50.28 | 5.33 |
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.